Baylis Medical Technologies

Executive Summary

Baylis Medical Technologies is a privately held medical device company specializing in advanced access tools for endovascular therapies, including radiofrequency (RF) guidewires, steerable sheaths, and capital equipment. Founded in 1986 and headquartered in Mississauga, Ontario, Canada, the company primarily serves the cardiovascular and peripheral vascular markets, with additional applications in biliary interventions. Baylis's technologies aim to help interventionalists navigate complex anatomy and treat challenging occlusions such as chronic total occlusions (CTOs). While the company has a long history, it remains privately held with limited public financial disclosures, suggesting a focus on organic growth and specialized product niches. Its product portfolio targets unmet needs in crossing difficult lesions, and the company may be poised for expansion through regulatory approvals and strategic partnerships.

Upcoming Catalysts (preview)

• Q3 2026FDA clearance for next-generation RF guidewire for CTO crossing65% success
• Q4 2026Exclusive distribution partnership with a major cardiovascular device company70% success
• Q2 2026Publication of pivotal clinical study results for steerable sheath in peripheral interventions60% success